ANDREA GULLETT: Open Payments
NPI 1679943377 · BROOKLINE, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$558 in 32 payments from 15 companies in 2025. Trend: 2023 $553 · 2024 $442 · 2025 $558
Food & beverage: $558
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $86 |
| PFIZER INC. | 4 | $66 |
| Lilly USA, LLC | 4 | $66 |
| Novo Nordisk Inc | 3 | $58 |
| Viatris Specialty LLC | 2 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
| ABBVIE INC. | 2 | $35 |
| Lundbeck LLC | 2 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $29 |
| Axsome Therapeutics, Inc. | 1 | $27 |
Products named: BREZTRI, JARDIANCE, NURTEC ODT, Wegovy, YUPELRI, TRINTELLIX, MOUNJARO, REXULTI.
Industry payments across MO — which companies pay providers there.
